Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

AIDS in Africa: distinguishing fact and fiction

  • 59 Accesses

  • 4 Citations

Abstract

The data widely purporting to show the existence and heterosexual transmission in Africa of a new syndrome caused by a retrovirus which induces immune deficiency are critically evaluated. It is concluded that both acquired immune deficiency (AID) and the symptoms and diseases which constitute the clinical syndrome (S) are of long standing in Africa, affect both sexes equally and are caused directly and indirectly by factors other than human immunodeficiency virus (HIV). Seropositivity to HIV in Africans usually represents no more than cross-reactivity caused by an abundance of antibodies induced by the numerous infectious and parasitic diseases which are endemic in Africa. The apparently high prevalence of ‘AIDS’ and ‘HIV’ seropositives is therefore not surprising and is not proof of heterosexual transmission of either HIV or AIDS.

This is a preview of subscription content, log in to check access.

References

  1. Anon. 1986 Acquired Immunodeficiency Syndrome (AIDS) WHO/CDC case definition for AIDS.Weekly Epidemiological Record 61, 69–76.

  2. Anon. 1989 Risk factors for male to female transmission of HIV.British Medical Journal 298, 411–414.

  3. AscherD.P. & RobertsC. 1993 Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting.Journal of Acquired Immune Deficiency Syndromes 6, 241–244.

  4. BiggarR.J. 1986 The AIDS problem in Africa.Lancet ii, 79–83.

  5. BiggarR.J., GigaseP.L., MelbyeM., KestensL., SarinP.S., DemedtsP., DelacolletteC., BodnerA.J., FalukuL., StevensW.J. & BattnerW.A. 1985 Elisa HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.Lancet ii, 520–523.

  6. BlattnerW.A. 1989 Retroviruses. InViral Infections of Humans 3rd edn., ed. EvansA.S. pp. 542–592. New York: Plenum Medical Book Company.

  7. BrennerB., SchwartzS., Ben-PorathE., TatarskyI., VaronD. & MartinowitzU. 1991. The prevalence and interaction of human immunodeficiency virus and hepatitis B infections in Israeli heamophiliacs.Israel Journal of Medical Sciences 27, 557–561.

  8. Brun-VezinetF., RouziouxC., MontagnierL., ChamaretS., GruestJ., Barre-SinoussiF., GeroldiD., ChermanJ.C., McCormickJ., MitchellS., PiotP., TaelmanH., MirlanguK.B., WobinO., MbendiN., MazeboP., KalambayiK., BridtsC., DesmyterJ., FeinsodF.M. & QuinnT.C. 1984 Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS.Science 226, 453–456.

  9. BurkeD.S., BrundageJ.F., RedfieldR.R., DamatoJ.J., SchableC.A., PutmanP., VisintineR. & KimH.J. 1988 Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.New England Journal of Medicine 319, 961–964.

  10. CaceresC.F. & VanGriensvenG.J.P. 1994 Male homosexual transmisison of HIV-1.AIDS 8, 1051–1061.

  11. Chamberland, M., Conley, L. & Dondero, T. 1988 Epidemiology and evolution of heterosexually acquired AIDS—United States. InAbstracts 4th International Conference on AIDS, p. 264. Stockholm.

  12. ChirimuutaR.C. & ChirimuutaR.J. 1987Aids, Africa and Racism. Bretby House, Stanhope, Bretby, Burton-on-Trent, UK: R. Chirimuuta.

  13. ClumeckN., Robert-GuroffM., Van DePerreP., JenningsA., SibomanaJ., DemolP., CranS. & GalloR.C. 1985 Seroepidemiological studies of HTVL-III antibody prevalence among selected groups of heterosexual Africans.Journal of the American Medical Association 254, 2599–2602.

  14. ClumeckN., SonnetJ., TaelmanH., Mascart-LemoneF., DeBruyereD., VandeperreP., DasnoyJ., MarcelisL., LamyM., JonasC., EyckmansL., NoelH., VanhaeverbeekM. & ButzlerJ.P. 1984 Acquired immunodeficiency syndrome in African patients.New England Journal of Medicine 310, 492–497.

  15. DonderoT.J. & CurranJ.W. 1994 Excess deaths in Africa from HIV: confirmed and quantified.Lancet i, 989.

  16. DuesbergP.H. 1989 Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.Proceedings of the National Academy of Sciences of the United States of America 86, 755–764.

  17. DuesbergP.H. 1993 AIDS acquired by drug consumption and other noncontagious risk factors.Pharmacology and Therapeutics 55, 201–277.

  18. HaverkosH.W. & EdelmanR. 1988 The epidemiology of acquired immunodeficiency syndrome among heterosexuals.Journal of the American Medical Association 260, 1922–1929.

  19. Hodgkinson, N. 1994 Research disputes epidemic of AIDS.Sunday Times, London 22 May, 24.

  20. KashalaO., MarlinkR., IlungaM., DieseM., GormusB., XuK., MukebaP., KasongoK. & EssexM. 1994 Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.Journal of Infectious Diseases 169, 296–304.

  21. KingsleyL.A., KaslowR., RinaldoC.R., DetreK., OdakaN., VanRadenM., DetelsR., PolkB.F., ChmielJ., KelseyS.F., OstrowD. & VisscherB. 1987 Risk factors for seroconversion to human immunodeficiency virus among male homosexuals.Lancet i, 345–348.

  22. Konotey-AhuluF.I.D. 1987 AIDS in Africa: misinformation and disinformation.Lancet ii, 206–207.

  23. Lucey, D., Hendrix, C. & Andrzejewski, C. 1991 Racial differences in anti-p24 antibody titers and total serum IGG levels in North American persons with HIV-1 infection. InAbstracts 7th International AIDS Conference I, p. 362. Florence.

  24. MannJ.M., FrancisH., QuinnT., AsilaP.K., BosengeN., NailambiN., BilaK., TamfumM., RutiK., PiotP., McCormickJ. & CurranJ.W. 1986 Surveillance for AIDS in a central African city.Journal of the American Medical Association 255, 3255–3259.

  25. MooreP.S., AllenS., SowellA.L., Van DePerreP., HuffD.L., SerufiliraA., NsengumuremyiF. & HulleyS.B. 1993 Role of nutritional status and weight loss in HIV seroconversion among Rwandan women.Journal of Acquired Immune Deficiency Syndromes 6, 611–616.

  26. MortimerP.P. 1989 The AIDS virus and the AIDS test.Medicine Internationale 56, 2334–2339.

  27. MortimerP.P., ParryJ.V. & MortimerJ.Y. 1985 Which anti-HTLV-III/LAV assays for screening and confirmatory testing?Lancet ii, 873–877.

  28. MulderD.W., NunnA.J., KamaliA., NaklylngiJ., WagnerH.U. & Kengeya-KayondoJ.F. 1994 Two-year HIV-1-associated mortality in a Ugandan rural population.Lancet i, 1021–1023.

  29. MullerW.E.G., SchroderH.C., ReuterP., MaidhofA., UhlenbruckG. & WinklerI. 1990 Polyclonal antibodies to mannan from yeast also recognize the carbohydrate structure of gp120 of the AIDS virus: an approach to raise neutralizing antibodies to HIV-1 infection in vitro.AIDS 4, 159–162.

  30. NunnA.J., BiryahwahoB., DowningR.G., Van DerGroenG., OjwiyaA. & MulderD.W. 1993 Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort.AIDS 7, 1057–1061.

  31. Nzilambi, N., Mann, J.M. & Francis, H. 1986 Seroprevalence among tuberculosis patients in Zaire. InAbstracts 2nd International AIDS Conference, p. S17b. Paris.

  32. PadianN. & PickeringJ. 1986 Female-to-male transmission of AIDS: a reexamination of the African sex ratio of cases.Journal of the American Medical Association 256, 590.

  33. PadianN.S., ShiboskiS.C. & JewellN.P. 1991 Female-to-male transmission of human immunodeficiency virus.Journal of the American Medical Association 266, 1664–1667.

  34. Papadopulos-EleopulosE., TurnerV.F. & PapdimitriouJ.M. 1992a Kaposi's Sarcoma and HIV.Medical Hypotheses 39, 22–29.

  35. Papadopulos-EleopulosE., TurnerV.F. & PapdimitriouJ.M. 1992b Oxidative stress, HIV and AIDS.Research in Immunology 143, 145–148.

  36. Papadopulos-EleopulosE., TurnerV.F. & PapdimitriouJ.M. 1993a Is a positive Western blot proof of HIV infection?Bio/Technology 11, 696–707.

  37. Papadopulos-EleopulosE., TurnerV.F. & PapadimitriouJ.M. 1993b Has Gallo proven the role of HIV in AIDS?Emergency Medicine (Australia) 5, 113–123.

  38. Papadopulos-Eleopopulos, E., Turner, V.F., Papadimitriou, J.M., Hedland-Thomas, B., Causer, D. & Page, B. 1994 A critical analysis of the HIV-T4-cell-AIDS hypothesis.Genetica (in press).

  39. PearceR.B. 1986 Heterosexual transmission of AIDS.Journal of the American Medical Association 256, 590–591.

  40. PiotP., TaelmanH., MinlanguK.B., WobinO., MbendiN., NdangiK., MazeboP., KalambayiK., BridtsC., FeinsodF.M., StevensW., QuinnT.C., MitchellS. & McCormickJ.B. 1984 Acquired immunodeficiency syndrome in a heterosexual population in Zaire.Lancet ii, 65–69.

  41. QuinnT.C., MannJ.M., CurranJ.W. & PiotP. 1986 AIDS in Africa: an epidemiologic paradigm.Science 234, 955–963.

  42. QuinnT.C., PiotP., McCormickJ.B., FeinsodF.M., TaelmanH., KapitaB., StevensW. & FauciA.S. 1987 Serologic and immunologic studies in patients with AIDs in North America and Africa.Journal of the American Medical Association 257, 2617–2621.

  43. SerwaddaD., SewankamboN.K., CarswellJ.W., BayleyA.C., TedderR.S., WeissR.A., MugerwaR.D., LwegabaA., KiryaG.B., DowningR.G., ClaydenS.A. & DagleishA.G. 1985 Slim disease: a new disease in Uganda and its association with HTLV-III infection.Lancet ii, 849–852.

  44. StreckerW., GurtlerL., BinibangiliM. & StreckerK. 1993 Clinical manifestations of HIV infection in Northern Zaire.AIDS 7, 597–598.

  45. TomiyamaT., LakeD., MasuhoY. & HershE.M. 1991 Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum.Biochemical and Biophysical Research Communications 177, 279–285.

  46. Van DePerreP., LepageP., KestelynP., HekkerA.C., RouvroyD., BogaertsJ., KayihigiJ., ButzlerJ.P. & ClumeckN., 1984 Acquired immunodeficiency syndrome in Rwanda.Lancet ii, 62–65.

  47. VoevodinA. 1992 HIV screening in Russia.Lancet i, 1548.

  48. WeissR. & ThierS.O. 1988 HIV testing is the answer—what's the question?New England Journal of Medicine 319, 1010–1012.

  49. WeissS.H., GoedertJ.J., SarngadharanM.G., BodnerA.J., GalloR.C. & BlattnerW.A. 1985 Screening test for HTLV-III (AIDS agent) antibodies.Journal of the American Medical Association 253, 221–225.

  50. Widy-WirskiR., BerkleyS., DowingR., OkwareS., RecineU. MugerwaR., LwegabaA. & SempalaS. 1988 Evaluation of the WHO clinical case definition for AIDS in Uganda.Journal of the American Medical Association 260, 3286–3289.

Download references

Additional information

E. Papadopulos-Eleopulos is with the Department of Medical Physics, The Royal Perth Hospital, Perth 6000, Western Australia, Australia; V.F. Turner is with the Department of Emergency Medicine, The Royal Perth Hospital, Perth 6000, Western Australia, Australia, J.M. Papadimitriou is with the Department of Pathology, University of Western Australia, Perth, Western Australia. H. Bialy is with Bio/Technology, 65 Becker St, New York, NY 10012, USA.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Papadopulos-Eleopulos, E., Turner, V.F., Papadimitriou, J.M. et al. AIDS in Africa: distinguishing fact and fiction. World J Microbiol Biotechnol 11, 135–143 (1995). https://doi.org/10.1007/BF00704634

Download citation

Key words

  • Acquired immunodeficiency syndrome
  • Africa
  • heterosexual transmission
  • human immunodeficiency virus
  • seropositivity